Linked Life Data

12087489

Source:http://linkedlifedata.com/resource/pubmed/id/12087489

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17-18
pubmed:dateCreated
2002-6-27
pubmed:abstractText
starting treatment of reactive macrophage activation syndromes as early as possible (rMAS, haemophagocytic lymphohistiocytosis), e.g., with intravenous immunoglobulins (IVIG), seems to be essential for optimal outcome. However, there is no diagnostic gold standard which reliably indicates need for early treatment. We used a simple screening strategy consisting of serum ferritin measurements and/or morphological assessment of haemophagocytosis and compared the studied patient population with published series.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1424-7860
pubmed:author
pubmed:issnType
Print
pubmed:day
4
pubmed:volume
132
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
230-6
pubmed:dateRevised
2011-2-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation.
pubmed:affiliation
Department of Medicine, University Hospital, Geneva, Switzerland.
pubmed:publicationType
Journal Article